United States Biotechnology & Medical Research

TCR2 Therapeutics Inc (TCRR)

Track

Ticker: TCRR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for TCR2 Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 25 May 2023
Value US$1,565,148.04 | Price 380.04 | Shares 95,424 (-40.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-30 2023-05-25 B Purchase
3.3
TANG KEVIN C
Large shareholder
95,424 -40.8%
380.04
US$1,565,148 		95,424 -40.8% 380.04 US$1,565,148
2023-05-24 2023-05-22 S Sale
3.1
GADICKE ANSBERT
Non-Executive Director Large shareholder
83,844 -17.9%
78.01
US$823,827 		83,844 -17.9% 78.01 US$823,827
2023-05-24 2023-05-22 S Sale
MPM ASSET MANAGEMENT LLC
Large shareholder
34,713 -12.1%
129.53
US$2,304,662 		34,713 -12.1% 129.53 US$2,304,662
2023-05-15 2023-05-12 B Purchase
3.3
TANG KEVIN C
Large shareholder
6,183 +0.1%
1.95
US$12,057 		6,183 +0.1% 1.95 US$12,057
2023-05-15 2023-05-11 B Purchase
3.3
TANG KEVIN C
Large shareholder
38,765 +0.9%
1.95
US$75,592 		38,765 +0.9% 1.95 US$75,592
2023-05-10 2023-05-10 B Purchase
3.3
TANG KEVIN C
Large shareholder
6,774 +0.2%
1.95
US$13,209 		6,774 +0.2% 1.95 US$13,209
2023-05-10 2023-05-09 B Purchase
3.3
TANG KEVIN C
Large shareholder
20,141 +0.5%
1.95
US$39,275 		20,141 +0.5% 1.95 US$39,275
2023-05-10 2023-05-08 B Purchase
3.3
TANG KEVIN C
Large shareholder
57,073 +1.4%
1.95
US$111,292 		57,073 +1.4% 1.95 US$111,292
2023-05-05 2023-05-05 B Purchase
3.3
TANG KEVIN C
Large shareholder
71,064 +1.7%
1.94
US$137,864 		71,064 +1.7% 1.94 US$137,864
2023-05-05 2023-05-05 B Purchase
3.3
TANG KEVIN C
Large shareholder
95,759 +2.4%
1.90
US$181,942 		95,759 +2.4% 1.90 US$181,942
2023-05-05 2023-05-04 B Purchase
3.3
TANG KEVIN C
Large shareholder
104,241 +2.6%
1.86
US$193,888 		104,241 +2.6% 1.86 US$193,888
2023-05-05 2023-05-03 B Purchase
3.3
TANG KEVIN C
Large shareholder
18,513 +0.5%
1.85
US$34,249 		18,513 +0.5% 1.85 US$34,249
2022-12-13 2022-12-13 PlS Planned sale
Olagunju Peter

Chief Technical Officer

Officer
1,659 -6.4%
1.07
US$1,767 		1,659 -6.4% 1.07 US$1,767
2022-12-13 2022-12-13 PlS Planned sale
3.2
Menzel Garry E

President and CEO

Executive Director
11,000 -7.3%
1.06
US$11,682 		11,000 -7.3% 1.06 US$11,682
2022-12-13 2022-12-13 PlS Planned sale
Cardama Alfonso Quintas

Chief Medical Officer

Officer
4,752 -4.2%
1.06
US$5,042 		4,752 -4.2% 1.06 US$5,042
2022-12-13 2022-12-12 PlS Planned sale
Olagunju Peter

Chief Technical Officer

Officer
1,610 -5.9%
1.10
US$1,766 		1,610 -5.9% 1.10 US$1,766
2022-12-13 2022-12-12 PlS Planned sale
3.2
Menzel Garry E

President and CEO

Executive Director
10,613 -6.6%
1.10
US$11,674 		10,613 -6.6% 1.10 US$11,674
2022-12-13 2022-12-12 PlS Planned sale
Justice Angela

Chief People Officer

Officer
2,963 -5.7%
1.06
US$3,150 		2,963 -5.7% 1.06 US$3,150
2022-12-13 2022-12-12 PlS Planned sale
Justice Angela

Chief People Officer

Officer
2,865 -5.2%
1.10
US$3,149 		2,865 -5.2% 1.10 US$3,149
2022-12-13 2022-12-12 PlS Planned sale
Cardama Alfonso Quintas

Chief Medical Officer

Officer
4,586 -3.9%
1.10
US$5,040 		4,586 -3.9% 1.10 US$5,040
2022-12-13 2022-12-09 PlS Planned sale
Olagunju Peter

Chief Technical Officer

Officer
1,561 -5.4%
1.13
US$1,765 		1,561 -5.4% 1.13 US$1,765
2022-12-13 2022-12-09 PlS Planned sale
3.2
Menzel Garry E

President and CEO

Executive Director
10,325 -6.0%
1.13
US$11,678 		10,325 -6.0% 1.13 US$11,678
2022-12-13 2022-12-09 PlS Planned sale
Justice Angela

Chief People Officer

Officer
2,792 -4.9%
1.13
US$3,149 		2,792 -4.9% 1.13 US$3,149
2022-12-13 2022-12-09 PlS Planned sale
Cardama Alfonso Quintas

Chief Medical Officer

Officer
4,461 -3.6%
1.13
US$5,041 		4,461 -3.6% 1.13 US$5,041
2022-12-09 2022-12-08 PlS Planned sale
Cardama Alfonso Quintas

Chief Medical Officer

Officer
4,014 -3.2%
1.26
US$5,042 		4,014 -3.2% 1.26 US$5,042
2022-12-09 2022-12-08 PlS Planned sale
Justice Angela

Chief People Officer

Officer
2,511 -4.2%
1.26
US$3,151 		2,511 -4.2% 1.26 US$3,151
2022-12-09 2022-12-08 PlS Planned sale
3.2
Menzel Garry E

President and CEO

Executive Director
9,314 -5.2%
1.25
US$11,680 		9,314 -5.2% 1.25 US$11,680
2022-12-09 2022-12-08 PlS Planned sale
Olagunju Peter

Chief Technical Officer

Officer
1,410 -4.6%
1.25
US$1,767 		1,410 -4.6% 1.25 US$1,767
2022-12-09 2022-12-07 PlS Planned sale
Cardama Alfonso Quintas

Chief Medical Officer

Officer
3,928 -3.0%
1.28
US$5,040 		3,928 -3.0% 1.28 US$5,040
2022-12-09 2022-12-07 PlS Planned sale
Justice Angela

Chief People Officer

Officer
2,457 -3.9%
1.28
US$3,150 		2,457 -3.9% 1.28 US$3,150
2022-12-09 2022-12-07 PlS Planned sale
3.2
Menzel Garry E

President and CEO

Executive Director
9,111 -4.8%
1.28
US$11,680 		9,111 -4.8% 1.28 US$11,680
2022-12-09 2022-12-07 PlS Planned sale
Olagunju Peter

Chief Technical Officer

Officer
1,378 -4.3%
1.28
US$1,767 		1,378 -4.3% 1.28 US$1,767
2022-12-07 2022-12-06 PlS Planned sale
Justice Angela

Chief People Officer

Officer
2,361 -3.6%
1.33
US$3,150 		2,361 -3.6% 1.33 US$3,150
2022-12-07 2022-12-06 PlS Planned sale
Olagunju Peter

Chief Technical Officer

Officer
1,327 -4.0%
1.33
US$1,765 		1,327 -4.0% 1.33 US$1,765
2022-12-07 2022-12-06 PlS Planned sale
Cardama Alfonso Quintas

Chief Medical Officer

Officer
3,778 -2.8%
1.33
US$5,040 		3,778 -2.8% 1.33 US$5,040
2022-12-07 2022-12-06 PlS Planned sale
3.2
Menzel Garry E

President and CEO

Executive Director
14,886 -7.3%
1.35
US$20,081 		14,886 -7.3% 1.35 US$20,081
2022-12-07 2022-12-05 PlS Planned sale
Justice Angela

Chief People Officer

Officer
2,302 -3.4%
1.37
US$3,161 		2,302 -3.4% 1.37 US$3,161
2022-12-07 2022-12-05 PlS Planned sale
Olagunju Peter

Chief Technical Officer

Officer
1,291 -3.8%
1.37
US$1,766 		1,291 -3.8% 1.37 US$1,766
2022-12-07 2022-12-05 PlS Planned sale
Cardama Alfonso Quintas

Chief Medical Officer

Officer
3,686 -2.7%
1.37
US$5,050 		3,686 -2.7% 1.37 US$5,050
2022-12-07 2022-12-05 PlS Planned sale
3.2
Menzel Garry E

President and CEO

Executive Director
8,530 -4.0%
1.37
US$11,703 		8,530 -4.0% 1.37 US$11,703
2022-12-05 2022-12-02 PlS Planned sale
Justice Angela

Chief People Officer

Officer
2,273 -3.3%
1.39
US$3,162 		2,273 -3.3% 1.39 US$3,162
2022-12-05 2022-12-02 PlS Planned sale
Olagunju Peter

Chief Technical Officer

Officer
1,273 -3.6%
1.39
US$1,766 		1,273 -3.6% 1.39 US$1,766
2022-12-05 2022-12-02 PlS Planned sale
3.2
Menzel Garry E

President & CEO

Executive Director
8,408 -3.8%
1.39
US$11,687 		8,408 -3.8% 1.39 US$11,687
2022-12-05 2022-12-02 PlS Planned sale
Cardama Alfonso Quintas

Chief Medical Officer

Officer
3,636 -2.6%
1.39
US$5,054 		3,636 -2.6% 1.39 US$5,054
2020-12-16 2020-12-14 PlS Planned sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
2,000 -57.6%
35.00
US$70,000 		2,000 -57.6% 35.00 US$70,000
2020-11-19 2020-11-17 PlS Planned sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
1,666 -53.1%
30.00
US$49,980 		1,666 -53.1% 30.00 US$49,980
2020-11-19 2020-11-17 PlS Planned sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
2,000 -38.9%
30.00
US$60,000 		2,000 -38.9% 30.00 US$60,000
2020-11-13 2020-11-12 PlS Planned sale
Hofmeister Robert

Chief Scientific Officer

Officer
10,002 -20.5%
25.10
US$251,050 		10,002 -20.5% 25.10 US$251,050
2020-11-13 2020-11-12 PlS Planned sale
Hofmeister Robert

Chief Scientific Officer

Officer
9,998 -20.5%
25.10
US$250,950 		9,998 -20.5% 25.10 US$250,950
2020-11-02 2020-10-29 PlS Planned sale
Hofmeister Robert

Chief Science Officer

Officer
20,000 -34.0%
19.10
US$382,000 		20,000 -34.0% 19.10 US$382,000
2020-03-27 2020-03-20 S Sale
0.8
Gibson Neil W
Non-Executive Director
648 -100.0%
7.94
US$5,145 		648 -100.0% 7.94 US$5,145
2020-03-27 2020-03-19 S Sale
0.8
Gibson Neil W
Non-Executive Director
3,140 -82.9%
7.41
US$23,267 		3,140 -82.9% 7.41 US$23,267
2020-03-27 2020-03-18 S Sale
0.8
Gibson Neil W
Non-Executive Director
3,120 -45.2%
6.83
US$21,310 		3,120 -45.2% 6.83 US$21,310
2020-03-27 2020-03-17 S Sale
0.8
Gibson Neil W
Non-Executive Director
3,009 -30.3%
6.49
US$19,528 		3,009 -30.3% 6.49 US$19,528
2020-03-27 2020-03-16 S Sale
0.8
Gibson Neil W
Non-Executive Director
17,723 -64.1%
6.60
US$117,043 		17,723 -64.1% 6.60 US$117,043
2020-03-27 2020-03-13 S Sale
0.8
Gibson Neil W
Non-Executive Director
52,000 -65.3%
6.52
US$338,894 		52,000 -65.3% 6.52 US$338,894
2019-12-26 2019-12-23 PlS Planned sale Baeuerle Patrick Non-Executive Director
84,907 -19.5%
15.44
US$1,310,964 		84,907 -19.5% 15.44 US$1,310,964
2019-12-26 2019-12-20 PlS Planned sale Baeuerle Patrick Non-Executive Director
32,022 -6.8%
15.16
US$485,454 		32,022 -6.8% 15.16 US$485,454
2019-12-20 2019-12-19 S Sale Jovan-Embiricos Morana Large shareholder
35,323 -18.5%
16.47
US$581,819 		35,323 -18.5% 16.47 US$581,819
2019-12-20 2019-12-19 S Sale Jovan-Embiricos Morana Large shareholder
6,642 -7.4%
16.47
US$109,403 		6,642 -7.4% 16.47 US$109,403
2019-12-20 2019-12-18 S Sale Jovan-Embiricos Morana Large shareholder
2,433 -1.3%
17.01
US$41,376 		2,433 -1.3% 17.01 US$41,376
2019-12-20 2019-12-18 S Sale Jovan-Embiricos Morana Large shareholder
458 -0.5%
17.01
US$7,789 		458 -0.5% 17.01 US$7,789
2019-12-11 2019-12-11 S Sale Jovan-Embiricos Morana Large shareholder
4,153 -0.3%
17.65
US$73,311 		4,153 -0.3% 17.65 US$73,311
2019-12-11 2019-12-11 S Sale Jovan-Embiricos Morana Large shareholder
1,054 -0.3%
17.65
US$18,606 		1,054 -0.3% 17.65 US$18,606
2019-12-11 2019-12-11 S Sale Jovan-Embiricos Morana Large shareholder
1,381 -0.3%
17.65
US$24,378 		1,381 -0.3% 17.65 US$24,378
2019-12-11 2019-12-11 S Sale Jovan-Embiricos Morana Large shareholder
1,155 -0.3%
17.65
US$20,389 		1,155 -0.3% 17.65 US$20,389
2019-12-11 2019-12-10 S Sale Jovan-Embiricos Morana Large shareholder
30,475 -2.3%
17.62
US$537,067 		30,475 -2.3% 17.62 US$537,067
2019-12-11 2019-12-10 S Sale Jovan-Embiricos Morana Large shareholder
7,741 -2.3%
17.62
US$136,421 		7,741 -2.3% 17.62 US$136,421
2019-12-11 2019-12-10 S Sale Jovan-Embiricos Morana Large shareholder
10,135 -2.3%
17.62
US$178,611 		10,135 -2.3% 17.62 US$178,611
2019-12-11 2019-12-10 S Sale Jovan-Embiricos Morana Large shareholder
8,479 -2.3%
17.62
US$149,427 		8,479 -2.3% 17.62 US$149,427
2019-12-11 2019-12-09 S Sale Jovan-Embiricos Morana Large shareholder
75,067 -5.3%
17.65
US$1,325,015 		75,067 -5.3% 17.65 US$1,325,015
2019-12-11 2019-12-09 S Sale Jovan-Embiricos Morana Large shareholder
19,070 -5.3%
17.65
US$336,606 		19,070 -5.3% 17.65 US$336,606
2019-12-11 2019-12-09 S Sale Jovan-Embiricos Morana Large shareholder
24,966 -5.3%
17.65
US$440,677 		24,966 -5.3% 17.65 US$440,677
2019-12-11 2019-12-09 S Sale Jovan-Embiricos Morana Large shareholder
20,886 -5.3%
17.65
US$368,661 		20,886 -5.3% 17.65 US$368,661
2019-10-24 2019-10-22 S Sale
3.5
Jovan-Embiricos Morana
Large shareholder
2,085 -0.1%
15.16
US$31,603 		2,085 -0.1% 15.16 US$31,603
Explore more

More insider trading research around TCR2 Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America